Ticagrelor
- Introduction
- Newest Products
Introduction
Ticagrelor
Ticagrelor, a new platelet aggregation inhibitor, is the world’s first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist. It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome. Ticagrelor is white to off-white powder with hygroscopic, so low temperature storage and transport is required.
Newest Products
| Image | Part # | Description | manufacturer | Stock | RFQ | |
|---|---|---|---|---|---|---|
|
|
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3H-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid 376608-65-0 |
CAS: 376608-65-0; Ticagrelor manufacturer; Ticagrelor intermediate; Cardio-Vascular
|
|
In Stock
|
|
|
|
|
4,6-dichloro-2-propylthiopyrimidine-5-amine (145783-15-9) |
CAS: 145783-15-9; Ticagrelor manufacturer; Ticagrelor intermediate; Cardio-Vascular
|
|
In Stock
|
|
|
|
|
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate (376608-71-8) |
CAS: 376608-71-8; Ticagrelor manufaturer; Ticagrelor intermediate; Cardio-Vascular
|
|
In Stock
|
|
|
|
|
Ticagrelor (274693-27-5) |
CAS: 274693-27-5; Ticagrelor manufacturer; Ticagrelor API; Cardio-Vascular
|
|
In Stock
|
|
|
|
|
Isopropylidene Ticagrelor (274693-26-4) |
CAS: 274693-26-4; Ticagrelor manufacturer; Ticagrelor intermediate; Cardio-Vascular
|
|
In Stock
|
|
